Cutaneous Lichen Planus (Localized)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for lichen planus. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for lichen planus is investigational.

Welche Evidenz existiert?

Tier C (investigational). Only case-report-level evidence; there are no randomized controlled trials. Evidence-based therapy for localized cutaneous lichen planus is potent topical corticosteroid (clobetasol 0.05 percent), topical calcineurin inhibitors (tacrolimus, pimecrolimus), and intralesional triamcinolone for hypertrophic lesions. Phototherapy (narrow-band UVB, PUVA) and systemic agents (acitretin, hydroxychloroquine, methotrexate) are used for widespread or recalcitrant disease. Oral, genital, and erosive subtypes require dermatologic specialty care.

Hauptrisiken

• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness at the application area for 5 to 10 days
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Koebner phenomenon (new lichen-planus lesions at bite sites in actively flaring disease)
• Post-inflammatory hyperpigmentation, especially in darker Fitzpatrick skin types
• Small permanent scars at bite sites
• Delay or replacement of evidence-based topical or systemic therapy

Wer dies nicht in Betracht ziehen sollte

• Patients with oral, genital, or erosive lichen planus subtypes
• Patients with active hepatitis C co-infection without hepatology management
• Patients with suspected lichenoid drug eruption (taper the offending medication first)
• Patients with weeping, eroded, or actively flaring lesions
• Patients on anticoagulants, with hemophilia, or with severe anemia
• Patients who have not tried first-line topical or intralesional corticosteroid

Was Sie Ihren Kliniker fragen sollten

• Has the diagnosis been confirmed by biopsy, especially if other diagnoses are possible?
• Have I been screened for hepatitis C (associated in some populations)?
• Is this a drug-induced lichenoid reaction (review all medications)?
• Have I tried potent topical corticosteroid (clobetasol) or intralesional triamcinolone?
• If widespread, am I a candidate for phototherapy (NB-UVB) or systemic therapy?
• What evidence supports leech therapy for lichen planus specifically?
• What is the practitioner's experience and Aeromonas-prevention plan?

Wann dringende medizinische Versorgung suchen

• Painful or rapidly enlarging mouth, throat, or genital ulcers (mucosal lichen planus — needs specialty care)
• Difficulty swallowing or hoarseness (esophageal or laryngeal involvement)
• Severe vulvovaginal or penile pain, scarring, or new urinary symptoms
• Spreading redness, warmth, pus, or red streaks (cellulitis)
• Bleeding from a bite site lasting more than 24 to 48 hours
• Fever above 38.0 C / 100.4 F or chills
• Hives, throat tightness, or breathing difficulty